Combination Adenovirus + Pembrolizumab to Trigger Immune Virus Effects

Clinical trial NCT02798406 · COMPLETED

Trial details

NCT number: NCT02798406
Sponsor: DNAtrix, Inc.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Brain Cancer Brain Neoplasm Glioma Glioblastoma Gliosarcoma Malignant Brain Tumor Neoplasm, Neuroepithelial Neuroectodermal Tumors Neoplasm by Histologic Type Neoplasm, Nerve Tissue Nervous System Diseases

Start date: 2016-10-06
Primary completion: 2021-03-17
Enrollment: 49

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.